Kuros Biosciences
Update in progressKURN.SW (Swiss)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Kuros Biosciences AG develops and commercializes biologic technologies for musculoskeletal care in the United States, the European Union, and abroad. It operates through Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an advanced bone graft with submicron NeedleGrip surface technology; MagnetOs Putty to fill bone voids; and Attrax, biphasic calcium phosphate grafts that mimic cancellous bone. It also handles Checkmate licensing. Founded 2016, headquartered in Schlieren, Switzerland.
Company score
- Sentiment
- 0.46
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.04
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.28
- Governance
- 0.09
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.12
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.29
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!